Publication:
104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain

dc.contributor.authorJuan Pereyra-Rodriguez, Jose
dc.contributor.authorDominguez-Cruz, Javier
dc.contributor.authorCarlos Armario-Hita, Jose
dc.contributor.authorRuiz-Villaverde, Ricardo
dc.contributor.authoraffiliation[Juan Pereyra-Rodriguez, Jose] Hosp Univ Virgen Rocio, Dermatol Unit, Seville, Spain
dc.contributor.authoraffiliation[Dominguez-Cruz, Javier] Hosp Univ Virgen Rocio, Dermatol Unit, Seville, Spain
dc.contributor.authoraffiliation[Carlos Armario-Hita, Jose] Hosp Univ Puerto Real, Dermatol Unit, Cadiz, Spain
dc.contributor.authoraffiliation[Ruiz-Villaverde, Ricardo] Hosp Univ San Cecilio, Dermatol Unit, Granada, Spain
dc.date.accessioned2023-02-12T02:20:30Z
dc.date.available2023-02-12T02:20:30Z
dc.date.issued2021-11-09
dc.identifier.doi10.1016/j.abd.2020.08.030
dc.identifier.essn1806-4841
dc.identifier.issn0365-0596
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.abd.2020.08.030
dc.identifier.urihttp://hdl.handle.net/10668/18667
dc.identifier.wosID716855900024
dc.issue.number6
dc.journal.titleAnais brasileiros de dermatologia
dc.journal.titleabbreviationAn. brasil. dermatol.
dc.language.isoen
dc.organizationHospital Universitario de Puerto Real
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.page.number787-790
dc.publisherElsevier science inc
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.title104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain
dc.typeletter
dc.type.hasVersionVoR
dc.volume.number96
dc.wostypeLetter
dspace.entity.typePublication

Files